On the other hand, a study investigating the role of UPR activation during the development of tau pathology in AD in vivo showed that UPR activation markers pPERK, pIRE1α, and peIF2α were elevated in AD hippocampus at an early Braak stage of tau pathology. Here, MAPT is linked to Alzheimer disease.